The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.65
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.25 (6.793%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 19.65
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BATM enters option agreement to sell NGSoft

12 Jan 2021 07:00

RNS Number : 3160L
BATM Advanced Communications Ld
12 January 2021
 

LEI: 213800FLQUB9J289RU66

12 January 2021

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

BATM enters option agreement to sell NGSoft for c. $33m

Disposal of legacy software services subsidiary to generate funds for acceleration of core activities

 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has entered into an option agreement (the "Option Agreement") to sell NG Soft Ltd. ("NGSoft"), a subsidiary of the Group, for NIS 105.1m (approximately $33m) in cash to Aztek Technologies (1984) Ltd., a provider of ICT cloud services in Israel and a portfolio company of SKY Fund (the "Buyer").

 

Background to the transaction

 

BATM is focused on core areas of activity, underpinned by the Group's portfolio of intellectual property, that it expects will offer transformational growth opportunities in both its Networking & Cyber and Bio-Medical divisions. In particular, in 2020, the Group achieved fundamental milestones in progressing the development of its network function virtualisation ("NFV") activities, including a successful proof-of-concept of its NFVTime solution with Vodafone and securing its first tier 1 customer with a multi-year licensing agreement. In medical diagnostics, the Bio-Medical division rapidly produced multiple solutions in response to the COVID-19 outbreak that are experiencing substantial demand as the global pandemic continues.

 

As previously stated, BATM continuously seeks opportunities to unlock shareholder value from Group subsidiaries that are considered non-core to the future of the Group. NGSoft is a software and digital services company that provides creative digital and technology solutions. Its development activities do not include any of the Group's NFV or cyber solutions. Accordingly, the Board believes that it would be in the best interests of BATM and of all shareholders to generate value from the sale of NGSoft and invest the proceeds to accelerate the Group's core activities in accordance with its strategic plan.

 

Terms of the transaction

 

Under the terms of the Option Agreement, BATM has the option, but not obligation, to sell the entire issued share capital of NGSoft for a total cash consideration of NIS 105.1m (c. $33m), of which the Group would receive a total of NIS 93.7m (c. $29m). The Group's consideration includes a NIS 15.5m loan repayment from NGSoft and a NIS 2.1m dividend payment, both to be received upon the exercise of the option. Certain employees of NGSoft would receive the balance of NIS 11.4m through cash out of their employee options and rights on completion.

 

In the event that the option is exercised by BATM, a share purchase agreement would be entered into - the final form of which has been agreed with the signatory pages being held in escrow by a trustee who would be required to release them upon being served with a notice of exercise of the option. The Buyer only has the right to terminate the agreement in the event of a material adverse change in the trading of NGSoft.

 

The Group's option is exercisable up to and including 1 March 2021, which, in accordance with the terms of the Option Agreement, can be extended by the Group to 17 May 2021 under certain predefined circumstances. If the Group does not exercise its option, it will be required to pay the Buyer a consideration of up to NIS 7.9m in cash.

 

The Group will update the market in due course.

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDKDBBCBKDBDD
Date   Source Headline
16th Dec 201012:57 pmRNSHolding(s) in Company
29th Nov 201011:30 amRNSDirectorate Change
10th Nov 20107:00 amRNSTrading Statement
28th Sep 20107:00 amRNSContract Win
13th Sep 20107:00 amRNSInterim Management Statement
10th Aug 20107:00 amRNSHalf Yearly Report
5th Aug 20107:00 amRNSInvestor Day
28th Jul 20107:00 amRNSNotice of Interim Results
28th Jun 20108:58 amRNSDirectorate Change
22nd Jun 201012:53 pmRNSResult of AGM
22nd Jun 20107:00 amRNSAGM Statement
14th Jun 20102:04 pmRNSHolding(s) in Company
2nd Jun 20102:50 pmRNSAnnual Information Update
20th May 201011:00 amRNSHolding(s) in Company
18th May 20104:25 pmRNSDirector/PDMR Shareholding
18th May 201011:24 amRNSDirector/PDMR Shareholding
18th May 20107:00 amRNSInterim Management Statement
12th May 20102:48 pmRNSNotice of IMS
30th Apr 20104:00 pmRNSAnnual Financial Report
22nd Apr 20107:00 amRNSLicensing Agreement
15th Mar 201010:47 amRNSHolding(s) in Company
15th Mar 201010:43 amRNSHolding(s) in Company
22nd Feb 201012:58 pmRNSDirector/PDMR Shareholding
18th Feb 20104:31 pmRNSHolding(s) in Company
9th Feb 20103:04 pmRNSDirector/PDMR Shareholding
8th Feb 201010:10 amRNSHolding(s) in Company
8th Feb 20107:00 amRNSFinal Results
1st Feb 201010:27 amRNSHolding(s) in Company
28th Jan 201010:00 amRNSNotice of Results
4th Jan 20109:01 amRNSHolding(s) in Company
16th Dec 20097:00 amRNSContract to develop & supply military comms
4th Dec 20099:27 amRNSHolding(s) in Company
29th Oct 20097:00 amRNSInterim Management Statement
19th Oct 200912:00 pmRNSDirector/PDMR Shareholding
19th Oct 200911:54 amRNSHolding(s) in Company
19th Oct 200911:54 amRNSHolding(s) in Company
15th Oct 20092:54 pmRNSDirector/PDMR Shareholding
26th Aug 20091:31 pmRNSDirector/PDMR Shareholding
20th Aug 20092:43 pmRNSHolding(s) in Company
13th Aug 20093:36 pmRNSDirector/PDMR Shareholding
4th Aug 20097:00 amRNSHalf Yearly Report
15th Jul 200910:00 amRNSNotice of Results
22nd Jun 20093:42 pmRNSResult of AGM
17th Jun 20097:00 amRNSAGM Statement
10th Jun 200911:37 amRNSHolding(s) in Company
19th May 20093:28 pmRNSAnnual Information Update
14th May 200911:34 amRNSDirector/PDMR Shareholding
12th May 20097:00 amRNSInterim Management Statement
30th Apr 20092:00 pmRNSAnnual Financial Report
31st Mar 20097:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.